BBI-001 for hemochromatosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Jan 2026: Trial registered, NCT07371793
  2. 4 May 2026: Trial started, NCT07371793

The trials

NCT07371793: A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis

State
Under way
Phase
Phase 1 and Phase 2
People
34 planned
Started
4 May 2026
Primary completion
Feb 2027
Arms
BBI-001
Results
None posted
  1. 28 Jan 2026: Trial registered
  2. 4 May 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.